🔎 Trials Near Me

ホーム › 肥満症 › モンタナ州

モンタナ州における肥満症の臨床試験

モンタナ州内の拠点で、肥満症に関する9件の研究が参加者を募集しています。

モンタナ州内の都市

公式研究テキスト（英語）

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • Mercury Street Medical /ID# 282016, Butte
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07752979

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Kalispell Regional Medical Center, Kalispell
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Missoula
被験者募集中第3相健康なボランティア歓迎
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Missoula
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284901

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

  • Kailera Clinical Site, Missoula
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/01更新 · NCT07284979

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  • Montana Medical Research, Missoula
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/08/27更新 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Butte
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Butte
  • ACCOMPLISH-1 Research Site, Missoula
被験者募集中第3相
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

  • Mercury Street Medical Group, PLLC, Butte
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/07/22更新 · NCT07477704

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。